Long‐term risks and benefits of oral anticoagulation in atrial fibrillation patients with cancer: A report from the <scp>GLORIA</scp>‐<scp>AF</scp> registry — Meng Li (2024) | RDL Network
Long‐term risks and benefits of oral anticoagulation in atrial fibrillation patients with cancer: A report from the <scp>GLORIA</scp>‐<scp>AF</scp> registry
Article 2024 en
Authors
ML
Meng Li
BH
Bi Huang
SL
Steven Ho Man Lam
Abstract
1 min read
Cancer is a common comorbidity in patients with AF and is associated with increased risk of composite of all-cause mortality and thromboembolism. Compared with VKA, NOACs was associated with a lower risk of composite events and showed an advantage in lower risk of thromboembolism, as well as a reduced risk of major bleeding when CAD was also present.
Yang Liu, Steven Ho Man Lam, Giulio Francesco Romiti, Bi Huang, Yang Chen, Tze-Fan Chao, Brian Olshansky, Kui Hong, Menno V. Huisman, Professor Gregory Lip
Giulio Francesco Romiti, Bernadette Corica, Tommaso Bucci, Giuseppe Boriani, Brian Olshansky, Tze‐Fan Chao, Menno V. Huisman, Marco Proietti, Professor Gregory Lip
Hongyu Liu, Yang Chen, Bi Huang, Steven Ho Man Lam, Giulio Francesco Romiti, Yang Liu, Brian Olshansky, Menno V. Huisman, Kui Hong, Tze-Fan Chao, Professor Gregory Lip
Giuseppe Boriani, Marco Proietti, Cécile Laroche, Laurent Fauchier, Francisco Marı́n, Michael Näbauer, Tatjana Potpara, Gheorghe‐Andrei Dan, Zbigniew Kalarus, Luigi Tavazzi, Aldo P. Maggioni, Professor Gregory Lip, Giuseppe Boriani, G Y H Lip, Luigi Tavazzi, Aldo P. Maggioni, G-A Dan, T Potpara, M Nabauer, Francisco Marı́n, Z Kalarus, A Goda,
Discussion(0)
No comments yet. Be the first to comment.